These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. The induction of tumor-specific CD4+ T cells via major histocompatibility complex class II is required to gain optimal anti-tumor immunity against B16 melanoma cell line in tumor immunotherapy using dendritic cells. Fujisawa Y; Nabekura T; Nakao T; Nakamura Y; Takahashi T; Kawachi Y; Otsuka F; Onodera M Exp Dermatol; 2009 Apr; 18(4):396-403. PubMed ID: 19054057 [TBL] [Abstract][Full Text] [Related]
30. Immunization of HLA-A2+ melanoma patients with MAGE-3 or MelanA peptide-pulsed autologous peripheral blood mononuclear cells plus recombinant human interleukin 12. Gajewski TF; Fallarino F; Ashikari A; Sherman M Clin Cancer Res; 2001 Mar; 7(3 Suppl):895s-901s. PubMed ID: 11300489 [TBL] [Abstract][Full Text] [Related]
31. The alternative open reading frame of LAGE-1 gives rise to multiple promiscuous HLA-DR-restricted epitopes recognized by T-helper 1-type tumor-reactive CD4+ T cells. Mandic M; Almunia C; Vicel S; Gillet D; Janjic B; Coval K; Maillere B; Kirkwood JM; Zarour HM Cancer Res; 2003 Oct; 63(19):6506-15. PubMed ID: 14559844 [TBL] [Abstract][Full Text] [Related]
32. [Immunotherapeutic efficacy of both helper T lymphocytes and cytotoxic T lymphocytes epitopes augmented dendritic cells tumor vaccine on gastric cancer]. Li Q; Zhang Y; Chen XH; Cao WX; Gu QL; Zhu ZG; Liu BY Zhonghua Wei Chang Wai Ke Za Zhi; 2006 Mar; 9(2):148-51. PubMed ID: 16555158 [TBL] [Abstract][Full Text] [Related]
33. Immune characterization of clinical grade-dendritic cells generated from cancer patients and genetically modified by an ALVAC vector carrying MAGE minigenes. Trakatelli M; Toungouz M; Lambermont M; Heenen M; Velu T; Bruyns C Cancer Gene Ther; 2005 Jun; 12(6):552-9. PubMed ID: 15665821 [TBL] [Abstract][Full Text] [Related]
34. Immune responses to a class II helper peptide epitope in patients with stage III/IV resected melanoma. Wong R; Lau R; Chang J; Kuus-Reichel T; Brichard V; Bruck C; Weber J Clin Cancer Res; 2004 Aug; 10(15):5004-13. PubMed ID: 15297401 [TBL] [Abstract][Full Text] [Related]
35. Blood dendritic cells generated with Flt3 ligand and CD40 ligand prime CD8+ T cells efficiently in cancer patients. Davis ID; Chen Q; Morris L; Quirk J; Stanley M; Tavarnesi ML; Parente P; Cavicchiolo T; Hopkins W; Jackson H; Dimopoulos N; Tai TY; MacGregor D; Browning J; Svobodova S; Caron D; Maraskovsky E; Old LJ; Chen W; Cebon J J Immunother; 2006; 29(5):499-511. PubMed ID: 16971806 [TBL] [Abstract][Full Text] [Related]
36. Regulatory T-cell response and tumor vaccine-induced cytotoxic T lymphocytes in human melanoma. Chakraborty NG; Chattopadhyay S; Mehrotra S; Chhabra A; Mukherji B Hum Immunol; 2004 Aug; 65(8):794-802. PubMed ID: 15336780 [TBL] [Abstract][Full Text] [Related]
37. Induction of potent antitumor immunity by intratumoral injection of interleukin 23-transduced dendritic cells. Hu J; Yuan X; Belladonna ML; Ong JM; Wachsmann-Hogiu S; Farkas DL; Black KL; Yu JS Cancer Res; 2006 Sep; 66(17):8887-96. PubMed ID: 16951206 [TBL] [Abstract][Full Text] [Related]
38. Interleukin 18 transfection enhances antitumor immunity induced by dendritic cell-tumor cell conjugates. Ju DW; Tao Q; Lou G; Bai M; He L; Yang Y; Cao X Cancer Res; 2001 May; 61(9):3735-40. PubMed ID: 11325846 [TBL] [Abstract][Full Text] [Related]
39. Vaccination of dendritic cells loaded with interleukin-12-secreting cancer cells augments in vivo antitumor immunity: characteristics of syngeneic and allogeneic antigen-presenting cell cancer hybrid cells. Suzuki T; Fukuhara T; Tanaka M; Nakamura A; Akiyama K; Sakakibara T; Koinuma D; Kikuchi T; Tazawa R; Maemondo M; Hagiwara K; Saijo Y; Nukiwa T Clin Cancer Res; 2005 Jan; 11(1):58-66. PubMed ID: 15671528 [TBL] [Abstract][Full Text] [Related]
40. Adenovirus-transduced dendritic cells stimulate cellular immunity to melanoma via a CD4(+) T cell-dependent mechanism. Steitz J; Brück J; Knop J; Tüting T Gene Ther; 2001 Aug; 8(16):1255-63. PubMed ID: 11509959 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]